Safety and immunogenicity of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine in adults and children in Vellore, South India.

by Venkata Raghava Mohan, Santosh Raj, Mandeep Singh Dhingra, Naveena Aloysia D'Cor, Ajit Pal Singh, Tarun Saluja, Deok Ryun Kim, Venkat Jayanth Midde, Yanghee Kim, Sridhar Vemula, Santhosh Kumar Narla, Binod Sah, Mohammad Ali
Published 2019-01-01

A randomized, observer-blind, controlled phase III clinical trial assessing safety and immunological non-inferiority of Vi-diphtheria toxoid versus Vi-tetanus toxoid typhoid conjug...

by Shipra Chaudhary, Gauri Shankar Shah, Nisha Keshary Bhatta, Prakash Poudel, Basant Rai, Surendra Uranw, Prashant Mani Tripathi, Basudha Khanal, Anup Ghimire, Nikita Rai, Birendra Prasad Gupta, Sridhar Vemula, T. Anh Wartel, Sushant Sahastrabuddhe, Tarun Saluja
Published 2023-01-01

Challenges and opportunities in setting up a phase III vaccine clinical trial in resource limited settings: Experience from Nepal

by Tarun Saluja, Bishnu Rath Giri, Shipra Chaudhary, Dipesh Tamrakar, Piush Kanodia, Sonali Palkar, Sridhar Vemula, Suchada Chinaworapong, Bomi Kim, Birendra Prasad Gupta, Sue Kyoung Jo, Sanet Aspinall, Ganesh Kumar Rai, Duncan Steele, Jerome H. Kim, T. Anh Wartel, Sushant Sahastrabuddhe
Published 2021-07-01